6-3113257-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PP3_ModeratePP5BS1_Supporting

The NM_001354930.2(RIPK1):​c.1934C>T​(p.Thr645Met) variant causes a missense change. The variant allele was found at a frequency of 0.000117 in 1,614,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T645T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 0 hom. )

Consequence

RIPK1
NM_001354930.2 missense

Scores

12
6
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:6U:1

Conservation

PhyloP100: 7.19
Variant links:
Genes affected
RIPK1 (HGNC:10019): (receptor interacting serine/threonine kinase 1) This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein plays a role in inflammation and cell death in response to tissue damage, pathogen recognition, and as part of developmental regulation. RIPK1/RIPK3 kinase-mediated necrosis is referred to as necroptosis. Genetic disruption of this gene in mice results in death shortly after birth. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.863
PP5
Variant 6-3113257-C-T is Pathogenic according to our data. Variant chr6-3113257-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 598788.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=3, Uncertain_significance=1, Pathogenic=1}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000112 (17/152280) while in subpopulation NFE AF= 0.00022 (15/68028). AF 95% confidence interval is 0.000135. There are 0 homozygotes in gnomad4. There are 6 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RIPK1NM_001354930.2 linkc.1934C>T p.Thr645Met missense_variant Exon 11 of 11 ENST00000259808.9 NP_001341859.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RIPK1ENST00000259808.9 linkc.1934C>T p.Thr645Met missense_variant Exon 11 of 11 5 NM_001354930.2 ENSP00000259808.3 Q13546-1

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
152162
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000220
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000558
AC:
14
AN:
251088
Hom.:
0
AF XY:
0.0000295
AC XY:
4
AN XY:
135736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000118
AC:
172
AN:
1461818
Hom.:
0
Cov.:
31
AF XY:
0.000118
AC XY:
86
AN XY:
727200
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000143
Gnomad4 OTH exome
AF:
0.000166
GnomAD4 genome
AF:
0.000112
AC:
17
AN:
152280
Hom.:
0
Cov.:
32
AF XY:
0.0000806
AC XY:
6
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000220
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000115
Hom.:
0
Bravo
AF:
0.0000907
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.0000659
AC:
8
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:6Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Immunodeficiency 57 Pathogenic:3
Apr 19, 2019
Baylor Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This c.1934C>T (p.T645M) variant has been previously reported in patients from two unrelated families with very early onset inflammatory bowel disease, diarrhea and recurrent infections [PMID 30591564] Functional studies showed that the T645M mutant proteins lead to impaired proinflammatory signaling, increased inflammasome activity and defective cell death response in intestinal epithelial cells [PMID 30591564] -

Nov 09, 2022
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

ACMG classification criteria: PS3 supporting, PM2 supporting, PM3 strong, PP3 supporting -

-
3billion
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.007%). Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product (PMID: 30591564). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.69; 3Cnet: 0.37). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with RIPK1 related disorder (ClinVar ID: VCV000598788 / PMID: 30591564). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -

Inborn error of immunity;C4749850:IL10-related early-onset inflammatory bowel disease Pathogenic:1
-
Klein lab, Ludwig-Maximilians-University
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: research

patients suffered from recurrent bacterial and/or viral infections and had episodes of diarrhea and/or colitis -

See cases Pathogenic:1
Jul 28, 2023
Gene Friend Way, National Innovation Center
Significance: Likely pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

This missense change has been observed in individual(s) with clinical features of RIPK1 deficiency (PMID: 30591564, 32181283). RIPK1 is an important regulator of inflammation and cell death. RIPK1-mediated necroptosis and neuroinflammation (PMID: 30467385), might contribute to the pathogenesis of Autism Spectrum disorder (ASD) (PMID: 31029798, 23147483). Many children with ASD experience diarhea and irritable bowel movement. In our study, an ASD patient carried this mutation. -

Autoinflammation with episodic fever and lymphadenopathy Pathogenic:1
Mar 26, 2024
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Uncertain:1
Dec 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 645 of the RIPK1 protein (p.Thr645Met). This variant is present in population databases (rs116040763, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of RIPK1 deficiency (PMID: 30591564, 32181283, 36466854, 36939041). ClinVar contains an entry for this variant (Variation ID: 598788). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects RIPK1 function (PMID: 30591564). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Pathogenic
0.25
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.50
D;D
Eigen
Pathogenic
0.94
Eigen_PC
Pathogenic
0.86
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.93
.;D
M_CAP
Uncertain
0.22
D
MetaRNN
Pathogenic
0.86
D;D
MetaSVM
Pathogenic
0.94
D
MutationAssessor
Pathogenic
4.0
H;H
PrimateAI
Uncertain
0.54
T
PROVEAN
Uncertain
-3.4
D;D
REVEL
Pathogenic
0.69
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;D
Vest4
0.80
MVP
0.98
MPC
0.83
ClinPred
1.0
D
GERP RS
5.9
Varity_R
0.62
gMVP
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs116040763; hg19: chr6-3113491; API